nuzyra
(omadacycline)Paratek Pharmaceuticals, Inc.
Usage: NUZYRA is indicated for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) caused by various susceptible microorganisms, including specific strains of bacteria like Streptococcus pneumoniae and Staphylococcus aureus.